human | Q5 |
P496 | ORCID iD | 0000-0002-9128-7013 |
P1153 | Scopus author ID | 6701588125 |
P735 | given name | Francisco | Q7201446 |
Francisco | Q7201446 | ||
P106 | occupation | researcher | Q1650915 |
P21 | sex or gender | male | Q6581097 |
Q45352035 | A comparative study of ultra-deep pyrosequencing and cloning to quantitatively analyze the viral quasispecies using hepatitis B virus infection as a model |
Q40192872 | A new HDV mouse model identifies mitochondrial antiviral signaling protein (MAVS) as a key player in IFN-β induction |
Q53822443 | Amino acid substitutions within HLA-B*27-restricted T cell epitopes prevent recognition by hepatitis delta virus-specific CD8+ T cells. |
Q46587742 | Analysis of hepatitis B genotype changes in chronic hepatitis B infection: Influence of antiviral therapy |
Q49514801 | Analysis of hepatitis B virus preS1 variability and prevalence of the rs2296651 polymorphism in a Spanish population |
Q45729441 | Applicability of real-time PCR combined with melting curve analysis for the study of hepatitis B virus genome mutations |
Q37420024 | Application of a diagnostic algorithm for the rare deficient variant Mmalton of alpha-1-antitrypsin deficiency: a new approach |
Q40419604 | Assessment of a Novel Automatic Real-Time PCR Assay on the Cobas 4800 Analyzer as a Screening Platform for Hepatitis C Virus Genotyping in Clinical Practice: Comparison with Massive Sequencing. |
Q59796469 | Baseline hepatitis C virus resistance-associated substitutions present at frequencies lower than 15% may be clinically significant |
Q47302853 | Characterization of Novel Missense Variants of SERPINA1 Gene Causing Alpha-1 Antitrypsin Deficiency |
Q58861568 | Characterization of the New Alpha-1-Antitrypsin-Deficient PI M-Type Allele, PI M vall d’hebron (Pro 369 →Ser) |
Q33961593 | Cirrhosis, liver transplantation and HIV infection are risk factors associated with hepatitis E virus infection |
Q34506624 | Clinical application of estimating hepatitis B virus quasispecies complexity by massive sequencing: correlation between natural evolution and on-treatment evolution |
Q57097288 | Clinical outcome of acute and chronic hepatitis delta over time: a long-term follow-up study |
Q35216125 | Community-based seroepidemiological survey of hepatitis E virus infection in Catalonia, Spain |
Q35880685 | Complex Genotype Mixtures Analyzed by Deep Sequencing in Two Different Regions of Hepatitis B Virus |
Q40682456 | Correction for Quer at al., High-Resolution Hepatitis C Virus Subtyping Using NS5B Deep Sequencing and Phylogeny, an Alternative to Current Methods |
Q58861557 | Cuantificación del antígeno de superficie del virus de la hepatitis B: implicaciones clínicas |
Q39063756 | Deep sequencing in the management of hepatitis virus infections. |
Q44680874 | Detection of hepatitis B precore mutants by the fluorescent linear polymerase chain reaction sequencing method. |
Q55259180 | Detection of hyper-conserved regions in hepatitis B virus X gene potentially useful for gene therapy. |
Q42232115 | Early predictors of antiviral treatment response in liver transplant recipients with recurrent hepatitis C genotype 1. |
Q51664034 | Emphysema due to alpha-antitrypsin deficiency: familial study of the YBARCELONA variant. |
Q58861548 | Erratum to “A new HDV mouse model identifies mitochondrial antiviral signaling protein (MAVS) as a key player in IFN-β induction” [J Hepatol 67 (2017) 669–679] |
Q36065068 | Evidence of an Exponential Decay Pattern of the Hepatitis Delta Virus Evolution Rate and Fluctuations in Quasispecies Complexity in Long-Term Studies of Chronic Delta Infection |
Q58861564 | Farmacocinética de la alfa-1-antitripsina utilizada en el tratamiento sustitutivo del enfisema congénito grave |
Q47141376 | Gene and miRNA expression profiles in PBMCs from patients with severe and mild emphysema and PiZZ alpha1-antitrypsin deficiency |
Q45748634 | Genetic alterations in the S gene of hepatitis B virus in patients with acute hepatitis B, chronic hepatitis B and hepatitis B liver cirrhosis before and after liver transplantation. |
Q48004435 | Genetic diagnosis of α1-antitrypsin deficiency using DNA from buccal swab and serum samples |
Q50545949 | HBV core region variability: effect of antiviral treatments on main epitopic regions. |
Q58578646 | HDV evolution-will viral resistance be an issue in HDV infection? |
Q34491877 | Hepatitis B virus genome variability and disease progression: the impact of pre-core mutants and HBV genotypes |
Q45417315 | Hepatitis B virus genotypes and G1896A precore mutation in 486 Spanish patients with acute and chronic HBV infection. |
Q43462569 | Hepatitis B virus polymerase variants associated with entecavir drug resistance in treatment-naive patients. |
Q42173073 | Hepatitis B virus quasispecies evolution after liver transplantation in patients under long-term lamivudine prophylaxis with or without hepatitis B immune globulin |
Q58861550 | Hepatitis B virus: The challenge of an ancient virus with multiple faces and a remarkable replication strategy |
Q42984816 | Hepatitis C virus Core Antigen as a predictor of non-response in genotype 1 chronic hepatitis C patients treated with peginterferon alpha-2b plus ribavirin |
Q58861576 | Hepatitis E infection in acute sporadic hepatitis in Spain |
Q45771876 | Hepatitis E virus infection in acute hepatitis in Spain. |
Q44996647 | Hepatitis E: scale of the problem in Spain |
Q40335058 | High HCV subtype heterogeneity in a chronically infected general population revealed by high-resolution hepatitis C virus subtyping |
Q28652352 | High-resolution hepatitis C virus subtyping using NS5B deep sequencing and phylogeny, an alternative to current methods |
Q42985791 | IL28B genetic variation and hepatitis C virus-specific CD4(+) T-cell responses in anti-HCV-positive blood donors |
Q42261817 | Identification of host and viral factors involved in a dissimilar resolution of a hepatitis C virus infection |
Q41923520 | Identification of sapovirus GV.2, astrovirus VA3 and novel anelloviruses in serum from patients with acute hepatitis of unknown aetiology. |
Q42197661 | Immunogenicity of hepatitis B vaccine in patients with inflammatory bowel disease and the benefits of revaccination. |
Q38229802 | Indications for active case searches and intravenous alpha-1 antitrypsin treatment for patients with alpha-1 antitrypsin deficiency chronic pulmonary obstructive disease: an update |
Q38175788 | Inference with viral quasispecies diversity indices: clonal and NGS approaches |
Q57778379 | Influence of deficient α1-anti-trypsin phenotypes on clinical characteristics and severity of asthma in adults |
Q45860637 | Influence of human immunodeficiency virus infection on cell-mediated immunity in chronic D hepatitis. |
Q45374496 | Infrequent detection of hepatitis E virus RNA in pregnant women with hepatitis E virus antibodies in Spain |
Q71699150 | Interferon vs. adenine arabinoside 5'-monophosphate in patients with anti-HBe-positive chronic hepatitis |
Q43897814 | Is hepatitis B virus subtype testing useful in predicting virological response and resistance to lamivudine? |
Q53137778 | Laboratory Diagnosis by Genotyping. |
Q37740855 | Laboratory testing of individuals with severe alpha1-antitrypsin deficiency in three European centres. |
Q58861569 | Letters to the Editor |
Q37221506 | Molecular epidemiology and putative origin of hepatitis C virus in random volunteers from Argentina |
Q46575508 | New hepatitis C virus genotype 1 subtype naturally harbouring resistance-associated mutations to NS5A inhibitors |
Q40422658 | New real-time-PCR method to identify single point mutations in hepatitis C virus. |
Q113251485 | Next-Generation Sequencing for Confronting Virus Pandemics |
Q42230868 | Phylogenetic demonstration of hepatitis E infection transmitted by pork meat ingestion |
Q58768677 | Pipeline for specific subtype amplification and drug resistance detection in hepatitis C virus |
Q38935930 | Prevalence and distribution of hepatitis C virus genotypes in Spain during the 2000-2015 period (the GEHEP 005 study). |
Q41922052 | Quantitative characterization of hepatitis delta virus genome edition by next-generation sequencing |
Q43117100 | Quantitative longitudinal evaluations of hepatitis delta virus RNA and hepatitis B virus DNA shows a dynamic, complex replicative profile in chronic hepatitis B and D. |
Q40987185 | Quasispecies dynamics in hepatitis C liver transplant recipients receiving grafts from hepatitis C virus infected donors |
Q36395364 | Quasispecies dynamics in main core epitopes of hepatitis B virus by ultra-deep-pyrosequencing |
Q37285249 | Quasispecies structure, cornerstone of hepatitis B virus infection: mass sequencing approach |
Q50886270 | Rapid detection of Mmalton α1-antitrypsin deficiency allele by real-time PCR and melting curves in whole blood, serum and dried blood spot samples. |
Q57777929 | Rare alpha-1-antitrypsin variants: are they really so rare? |
Q58786455 | Real world evaluation of a novel lateral flow assay (AlphaKit® QuickScreen) for the detection of alpha-1-antitrypsin deficiency |
Q48012815 | Red blood cell transfusion-transmitted acute hepatitis E in an immunocompetent subject in Europe: a case report |
Q44131409 | Redetection of HBV lamivudine-resistant mutations in a patient under entecavir therapy, who had been treated sequentially with nucleos(t)ide analogues |
Q58861554 | Registro español de pacientes con déficit de alfa-1 antitripsina: evaluación de la base de datos y análisis de la población incluida |
Q42208612 | Relevance of a full-length genomic RNA standard and a thermal-shock step for optimal hepatitis delta virus quantification |
Q42986040 | Response-guided therapy for chronic hepatitis C virus infection in patients coinfected with HIV: a pilot trial. |
Q40251459 | Selection of the highly replicative and partially multidrug resistant rtS78T HBV polymerase mutation during TDF-ETV combination therapy |
Q40294468 | Serum hepatitis B core-related antigen is more accurate than hepatitis B surface antigen to identify inactive carriers, regardless of hepatitis B virus genotype |
Q34325994 | Severe alpha-1 antitrypsin deficiency in composite heterozygotes inheriting a new splicing mutation QOMadrid |
Q58854025 | Sofosbuvir and daclatasvir in mono- and HIV-coinfected patients with recurrent hepatitis C after liver transplant |
Q39669674 | Spanish Registry of Patients With Alpha-1 Antitrypsin Deficiency: Database Evaluation and Population Analysis |
Q39689447 | Sporadic cases of acute autochthonous hepatitis E in Spain |
Q43977371 | Study of hepatitis B virus replication and infection by other hepatitis viruses in patients with chronic hepatitis B virus infection |
Q37616336 | Successful use of entecavir for a severe case of reactivation of hepatitis B virus following polychemotherapy containing rituximab |
Q41163712 | Tenofovir discontinuation after long-term viral suppression in HBeAg negative chronic hepatitis B. Can HBsAg levels be useful? |
Q37142007 | The dynamic DNA methylomes of double-stranded DNA viruses associated with human cancer |
Q58861572 | The value of quantiative detection of HBV-DNA amplified by PCR in the study of hepatitis B infection |
Q45747052 | Transmission of hepatitis B virus by transplantation of livers from donors positive for antibody to hepatitis B core antigen. |
Q101051714 | Trends in Diagnosis of Alpha-1 Antitrypsin Deficiency Between 2015 and 2019 in a Reference Laboratory |
Q42977026 | Twelve-week posttreatment follow-up to predict sustained virologic response for recurrent hepatitis C infection in liver recipients |
Q30726364 | Ultra-deep pyrosequencing (UDPS) data treatment to study amplicon HCV minor variants. |
Q38830111 | Ultra-deep pyrosequencing analysis of the hepatitis B virus preCore region and main catalytic motif of the viral polymerase in the same viral genome |
Q28484005 | Ultra-deep pyrosequencing detects conserved genomic sites and quantifies linkage of drug-resistant amino acid changes in the hepatitis B virus genome |
Q43179791 | Use of the novel INNO-LiPA line probe assay for detection of hepatitis B virus variants that confer resistance to entecavir therapy |
Q44967742 | Usefulness of dried blood samples for quantification and molecular characterization of HBV-DNA. |
Q53085945 | Utility of oligoclonal IgG band detection for MS diagnosis in daily clinical practice. |
Q35984339 | Viral quasispecies complexity measures. |
Q58861561 | Virología molecular del virus de la hepatitis B |
Q54379182 | [Diagnosis of alpha-1 antitrypsin deficiency: limitations of rapid diagnostic laboratory tests]. |
Q50553132 | [Hepatitis E: molecular virology, epidemiology and pathogenesis]. |
Q48778639 | α1-Antitrypsin in fibromyalgia: results of a randomized, placebo-controlled, double-blind and crossover pilot trial |